US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed
Friday, 15 February 2013
AstraZeneca today announced that, on 14 February 2013, the
United States Court of Appeals for the Federal Circuit summarily
upheld a lower court ruling that had found the formulation patent
protecting SEROQUEL XR (quetiapine…
To Read More Visit FDA Drugs:
State Medical Board | Board of Doctors | Meds Drugstore | Order Meds Online No Prescription
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed
Friday, 15 February 2013
AstraZeneca today announced that, on 14 February 2013, the
United States Court of Appeals for the Federal Circuit summarily
upheld a lower court ruling that had found the formulation patent
protecting SEROQUEL XR (quetiapine…
To Read More Visit FDA Drugs:
Internet Med-board | California Medical Board | Med Drugs | Order Meds Online Global Shipping
Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement
WHITEHOUSE STATION, N.J. & SEOUL, South Korea–(BUSINESS
WIRE)–Merck, (NYSE: MRK) known as MSD outside the United States
and Canada, and Samsung Bioepis Co., Ltd., entered into an
agreement to develop and commercialize multiple pre-specified…
To Read More Visit FDA Drugs:
California Medical Board | Internet Med-board | Online Meds Drugs | Order Meds Rx Online
FDA Approves Generic Suboxone
Feb. 25, 2013 — The United States Food and Drug Administration (FDA) has approved generic versions of Reckitt Benckiser Healthcare’s Suboxone sublingual tablets. Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg…
To Read More Visit FDA Drugs:
shop Med-board | Board of Doctors | buy Meds Drugs | Prescription Meds Online Order
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib capsules)
NEW YORK–(BUSINESS WIRE)–Mar 5, 2013 – Pfizer Inc. announced
today that the United States Patent & Trademark Office has
granted Pfizer a reissue patent (U.S. Patent No. RE44048), covering
methods of treating osteoarthritis and other…
To Read More Visit FDA Drugs:
Med Board of Doctors | Medical Boards | Meds-Drugs | Order Meds Rx Online
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Mar 7, 2013 – Merck
(NYSE: MRK), known as MSD outside the United States and Canada,
today announced the appointment of Roger M. Perlmutter, M.D.,
Ph.D., as executive vice president and president of Merck…
To Read More Visit FDA Drugs:
Med-board Online | AZ Medical Board | Meds Drugstore | Order Online Meds
